|
|
News Breaks | | | | January 16, 2013 | | 09:55 EDT |  | ONXX | Onyx Pharmaceuticals trades below spot secondary price of $81.50
The stock last traded at $81.22, just below the 4.4 million share spot secondary price of $81.50. Next support is at $80.48. Resistance is at $81.50, and then the 10-day moving average at $82.68. | |
|
News For ONXX From The Last 14 Days Check below for free stories on ONXX the last two weeks. |
|
|
| June 13, 2013 | | 07:57 EDT |  | ONXX | European Hematology Association to host annual meeting
Annual Meeting of the EHA will be held in Stockholm, Sweden on June 13-16. | | | June 4, 2013 | | 08:03 EDT |  | ONXX | Onyx Pharmaceuticals shares should be bought on weakness, says JMP Securities
After reviewing additional data on the efficacy of Onyx's KMP as a multiple myeloma treatment, JMP Securities continues to be upbeat on the drug's outlook and keeps an Outperform rating on Onyx. | |
|
|
|
|
|
|
